301037.SZ
Shanghai Baolijia Chemical Co., Ltd.
SZSE · C 制造业 · CN
CNY 11.15
+1.55%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.6B | 1.7B | 2.2B | 2.3B | 3.2B |
| Cost of Revenue | 1.4B | 1.5B | 1.9B | 2.0B | 2.8B |
| Gross Profit | 195.2M | 215.3M | 217.2M | 296.4M | 333.3M |
| Operating Expenses | |||||
| R&D Expense | 26.5M | 28.0M | 45.0M | 70.0M | 51.3M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 82.1M | 83.6M | 97.7M | 97.4M | 82.2M |
| Selling & Marketing Expense | 100.8M | 104.3M | 125.1M | 135.3M | 142.2M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 259.3M | 266.4M | 319.1M | 345.9M | 326.3M |
| Cost and Expenses | 1.7B | 1.7B | 2.3B | 2.3B | 3.2B |
| Operating Income (EBIT) | (63.7M) | (47.8M) | (129.2M) | (41.2M) | 3.2M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (64.0M) | (48.1M) | (134.6M) | (42.0M) | 2.7M |
| Income Tax Expense | 7.1M | 7.4M | 15.3M | (10.5M) | (3.0M) |
| Bottom Line | |||||
| Net Income | (71.1M) | (55.4M) | (149.7M) | (31.3M) | 5.7M |
| Earnings from Cont. Ops | (71.1M) | (55.5M) | (150.0M) | (31.5M) | 5.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (71.1M) | (55.4M) | (149.7M) | (31.3M) | 5.7M |
| Per Share | |||||
| Basic EPS | (CN¥0.51) | (CN¥0.40) | (CN¥1.08) | (CN¥0.22) | CN¥0.06 |
| Diluted EPS | (CN¥0.51) | (CN¥0.40) | (CN¥1.08) | (CN¥0.22) | CN¥0.06 |
| Revenue Per Share | CN¥11.65 | CN¥12.14 | CN¥15.45 | CN¥16.13 | CN¥31.59 |
| Shares | |||||
| Basic Shares Outstanding | 139.0M | 139.2M | 139.2M | 140.7M | 100.1M |
| Diluted Shares Outstanding | 139.0M | 139.2M | 139.2M | 140.7M | 100.1M |
| Profitability Metrics | |||||
| EBITDA | — | 33.7M | (50.0M) | 21.7M | 48.5M |
| D&A | — | 81.6M | 79.2M | 62.9M | 45.2M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026